作者
Matteo Ferro, Giuseppe Lucarelli, Dario Bruzzese, Giuseppe Di Lorenzo, Sisto Perdonà, Riccardo Autorino, Francesco Cantiello, Roberto La Rocca, Gian Maria Busetto, Amelia Cimmino, Carlo Buonerba, Michele Battaglia, Rocco Damiano, Ottavio De Cobelli, Vincenzo Mirone, Daniela Terracciano
发表日期
2017/3/3
期刊
Oncotarget
卷号
8
期号
11
页码范围
18424
出版商
Impact Journals, LLC
简介
Active surveillance (AS) is currently a widely accepted treatment option for men with clinically localized prostate cancer (PCa). Several reports have highlighted the association of low serum testosterone levels with high-grade, high-stage PCa. However, the impact of serum testosterone as a predictor of progression in men with low-risk PCa has been little assessed.
学术搜索中的文章
M Ferro, G Lucarelli, D Bruzzese, G Di Lorenzo… - Oncotarget, 2017